Immunomodulatory and immunorestorative activities of β-D-glucan-rich extract and polysaccharide fraction of mushroom, Pleurutus tuberregium

Pharmaceutical Biology

Volumn 53, Issue 11, 2015, Pages 1555-1566

  Nworu, Chukwuemeka S ^a   Ihim, Stella A ^a   Okoye, Festus B C ^b   Esimone, Charles O ^b   Adikwu, Michael U ^a   Akah, Peter A ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

Author keywords

Anti ovalbumin; ELISA; Hemagglutination; Immunomodulation; Immunorestoration; Oyster mushroom

Indexed keywords

BETA GLUCAN; DEXAMETHASONE; ERYTHROCYTE ANTIBODY; FUNGAL EXTRACT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MORINDA CITRIFOLIA EXTRACT; NITRIC OXIDE; OVALBUMIN; PLEUROTUS TUBERREGIUM EXTRACT; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BETA-1,3-D-GLUCAN; IMMUNOLOGIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; AQUEOUS SOLUTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DRUG DOSE COMPARISON; DRUG STRUCTURE; FEMALE; HEMAGGLUTINATION TEST; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PLEUROTUS; PLEUROTUS TUBERREGIUM; PROTEIN EXPRESSION; SPLEEN WEIGHT; ANIMAL; CELL LINE; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MACROPHAGE;

ANIMALS; BETA-GLUCANS; CELL LINE; FEMALE; IMMUNOLOGIC FACTORS; MACROPHAGES; MALE; MICE; PLEUROTUS; POLYSACCHARIDES;

EID: 84945895835     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.991838     Document Type: Article

References (73)

1. Abdullah N, Ismail SM, Aminudin N, et al. (2012). Evaluation of selected culinary medicinal mushrooms for anti-oxidant and ACE inhibitory activities. Evid Based Complement Alternat Med 2012: 464238. doi: 10.1155/2012/464238
2. Adotey G, Quarcoo A, Holliday JC, et al. (2011). Effect of immunomodulating and anti-viral agent of medicinal mushrooms (immune assist 24/7) on CD4+ T-lymphocyte counts of HIV-infected patients. Int J Med Mushroom 13:109-13
3. Akpaja EO, Iskhuemhen OS, Okhuoya JA. (2003). Ethnomycology and uses of edible and medicinal mushrooms among the Igbo people of Nigeria. Int J Med Mushroom 5:313-19
4. Alves MJ, Ferreira IC, Martins A, Pintado M. (2012). Anti-microbial activity of wild mushroom extracts against clinical isolates resistant to different antibiotics. J Appl Microbiol 113:466-75
5. Aswell JD, Lu FW, Vacchio MS. (2000). Glucocorticoids in T cell development and function. Ann Rev Immunol 18:309-45
6. Barcotti A, Welker RD, Piccoli M, et al. (1984). Immunosuppressive effects of human chorionic gonadotropin on delayed-type hypersensitivity in mice. In: Fenichel RL, Chirigos MA, eds. Immune Modulation Agents and their Mechanism. Vol. 25. New York: Marcel Decker Inc., 597-605
7. Barnes PJ. (1998). Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin Sci (London) 94:557-72
8. Basu SK, Thomas JE, Acharya SN. (2007). Prospects for growth in global nutraceutical and functional food markets: A Canadian perspective. Aust J Basic Appl Sci 1:637-49
9. Biedermann TR, Mailhammer AMC, Sander A, et al. (2001). Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen specific Th2 cells. Eur J Immunol 5:1582-91
10. Borchers AT, Krishnamurthy A, Keen CL, et al. (2008). The immunobiology of mushrooms. Exp Biol Med (Maywood) 233: 259-76
11. Borchers AT, Stern JS, Hackman RM, et al. (1999). Mushrooms, tumors and immunity. Proc Soc Exp Biol Med 221:281-93
12. Brooks VJ, Schafer M, Sharp P, et al. (2009). Effects of Morinda citrifolia (Noni) on CD4+ and CD8+ T-cell activation in neonatal calves. Profess Anim Sci 20:202-6
13. Brown GD, Gordon S. (2001). Immune recognition. A new receptor for b-glucans. Nature 413:36-7
14. Brown GD, Taylor PR, Reid DM, et al. (2002). Dectin-1 is a major betaglucan receptor on macrophages. J Exp Med 196:407-12
15. Chatterjee D, Roberts AD, Lowell K, et al. (1992). Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun 60:1249-53
16. Chen JR, Yang ZQ, Hu TJ, et al. (2010). Immunomodulatory activity in vitro and in vivo of polysaccharide from Potentilla anserina. Fitoterapia 81:1117-24
17. Davis L, Kuttan G. (2000). Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 71:193-200
18. Eo SK, Kim YS, Lee CK, Han SS. (1999). Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacol 68:129-36
19. European Union. (2010). Protection of animals used for scientific purposes. Directive No. 2010/63/EU
20. Evans WC. (2009). Trease and Evans Pharmacognosy, 16th ed. Edinburgh: WB Saunders
21. Fisher M, Yang LX. (2002). Anticancer effects and mechanisms of polysaccharide-K (PSK): Implications of cancer immunotherapy. Anticancer Res 22:1737-54
22. Furusawa E, Hirazumi A, Story S, Jensen J. (2003). Antitumor potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) on sarcoma 180 ascitestumour in mice. Phytother Res 17:1158-64
23. Gbolagade JS, Ajayi A, Oku I, Wankasi D. (2006). Nutritive value of common wild edible mushrooms from southern Nigeria. Global J Biotechnol Biochem 1:16-21
24. Gupta A, Gautam MK, Singh RK, et al. (2010). Immunomodulatory effect of Moringa oleifera Lam. extract on cyclophosphamide induced toxicity in mice. Indian J Exp Biol 48:1157-60
25. Gussow L. (2000). The optimal management of mushroom poisoning remains undetermined. West J Med 173:317-18
26. Hall IR, Stephenson SL, Buchanan PK, et al. (2003). Edible and Poisonous Mushrooms of the World. Portland, OR: Timber Press Inc, 103-34
27. Harborne JB. (1998). Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis, 3rd ed. London: Chapman & Hall
28. Hirazumi A, Furusawa E, Chou SC, Hokama Y. (1996). Immunomodulation contributes to the anticancer activity of Morinda citrifolia (Noni) fruit juice. Proc West Pharmacol Soc 39: 7-9
29. Hirazumi A, Furusawa E. (1999). An immunomodulatory polysaccharide rich substance from the fruit juice of Morinda citrifolia (Noni) with antitumor activity. Phytother Res 13:380-7
30. Huang HY, Korivi M, Chaing YY, et al. (2012). Pleurotus tuberregium polysaccharides attenuates hyperglycemia and oxidative stress in experimental diabetic rats. Evid Based Complement Alternat Med 2012:856381. doi: 10.1155/2012/856381
31. Ikewuchi CC, Ikewuchi JC. (2008). Chemical profile of Pleurotus tuberregium (Fr) Sing's Sclerotia. Pacific J Sci Technol 10:295-9
32. Jones K. (1998). Maitake: A potent medicinal food. Alt Comparative Therapy 4:420-9
33. Jong SC, Birmingham JM, Pai SH. (1991). Immunomodulatory substances of fungal origin. J Immunopharmacy 3:115-22
34. Kidd PM. (2000). The use of mushroom glucans and proteoglycans in cancer treatment. Alt Med Rev 5:4-27
35. Kim GY, Choi GS, Lee SH, Park YM. (2004). Acidic polysaccharide isolated from Phellinus linteus enhances through the up-regulation of nitric oxide and tumor necrosis factor-a from peritoneal macrophages. J Ethnopharmacol 95:69-76
36. Kleinert H, Schwarz PM, Förstermann U. (2003). Regulation of the expression of inducible nitric oxide synthase. Biol Chem 384: 1343-64
37. Liu F, Ooi VEC, Fung MC. (1999). Analysis of immunomodulating cytokines RNAs in the mouse induced by mushroom polysaccharides. Life Sci 64:1005-11
38. Liu KC, Phounsavan SF, Huang RL, et al. (1998). Pharmacological and liver functional studies on mycelium of Ganoderma lucidum. Chin Pharm J 40:21-9
39. Lorke D. (1983). A new approach to practical acute toxicity testing. Arch Toxicol 54:275-87
40. Lull C, Wichers HJ, Savelkoul HF. (2005). Antiinflammatory and immunomodulating properties of fungal metabolites. Mediators Inflamm 2005:63-80
41. Mattila P, Könkö K, Eurola M, et al. (2001). Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms. J Agric Food Chem 49:2343-8
42. McEwen BS, Biron CA, Brunson KW, et al. (1997). The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions. Brain Res Rev 23:79-133
43. Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
44. Mujić I, Zeković Z, Vidović S, et al. (2011). Fatty acid profiles of four wild mushrooms and their potential benefits for hypertension treatment. J Med Food 14:1330-7
45. Novak M, Vetvicka V. (2008). b-Glucans, history, and the present: Immunomodulatory aspects and mechanisms of action. J Immunotoxicol 5:47-57
46. Nworu CS, Akah PA, Esimone CO, et al. (2008). Immunomodulatory activities of Kolaviron, a mixture of three related biflavonoids of Garcinia kola Heckel. Immunopharmacol Immunotoxicol 30:317-32
47. Nworu CS, Akah PA, Okoli CO, et al. (2007). The effects of methanolic seed extract of Garcinia kola on some specific and non-specific immune responses in mice. Int J Pharmacol 3:347-51
48. Nworu CS, Akah PA, Okoye FBC, Esimone CO. (2010a). Aqueous extract of Phyllanthus niruri (Euphorbiaceae) enhances the phenotypic and functional maturation of bone marrow-derived dendritic cells and their antigen presentation function. Immunopharmacol Immunotoxicol 32:393-401
49. Nworu CS, Ihim SA, Ugwu LE, et al. (2014). Hepato- and nephroprotective activities of a Nigerian local King Tuber Oyster mushroom, Pleurotus tuberregium (Higher Basidiomycetes), in chemically-induced organ toxicities in rats. Int J Med Mush 16: 305-18
50. Nworu CS, Temchura V, Okoye FBC, et al. (2010b). Activation of murine lymphocytes and modulation of macrophage functions by fractions of Alchornea cordifolia (Euphorbiaceae) leaf extract. Immunopharmacol Immunotoxicol 32:28-36
51. Ooi VEC, Liu F. (1999). A review of pharmacological activities of mushroom polysaccharides. Int J Med Mush 1:195-206
52. Osemwegie OO, Eriyaremu EG, Abdulmalik J. (2006). A survey of macrofungi in Edo/Delta region of Nigeria, their morphology and uses. Global J Pure Appl Sci 12:149-57
53. Pier GB, Lyczak JB, Wetzler LM. (2004). Immunology, Infection, and Immunity. Washington: ASM Press
54. Preuss HG, Echard B, Fu J, et al. (2012). Fraction SX of maitake mushroom favorably influences blood glucose levels and blood pressure in streptozotocin-induced diabetic rats. J Med Food 15: 901-8
55. Rahar S, Swami G, Nagpal N, et al. (2011). Preparation, characterization, and biological properties of b-glucans. J Adv Pharm Technol Res 2: 94-103
56. Ravi B, Renitta RE, Prabha ML, et al. (2013). Evaluation of anti-diabetic potential of oyster mushroom (Pleurotus ostreatus) in alloxan-induced diabetic mice. Immunopharmacol Immunotoxicol 35:101-9
57. Rincão VP, Yamamoto KA, Ricardo NM, et al. (2012). Polysaccharide and extracts from Lentinula edodes: Structural features and antiviral activity. Virol J 9:37. doi: 10.1186/1743-422X-9-37
58. Robyt JF. (1998). Essentials of Carbohydrate Chemistry. Vol. 3. Berlin: Springer Verlag Inc, 1-2
59. Roupas P, Keogh J, Noakes M, et al. (2012). The role of edible mushrooms in health: Evaluation of the evidence. J Funct Foods 4:687-709
60. Schmid F, Stone BA, McDougall BM, et al. (2001). Structure of epiglucan, a highly side-chain/branched(1!3;1!6)-b-glucan from the micro fungus Epicoccum nigrum Ehrenb. ex Schlecht. Carbohydr Res 331:163-71
61. Smith JE, Rowan NJ, Sullivan R. (2002). Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatments. Strathclyde, UK: Cancer Research (UK), 1-256
62. Smoak KA, Cidlowski JA. (2004). Mechanisms of glucocorticoid receptor signaling during inflammation. Mech Aging Dev 125: 697-706
63. Torisu M, Hayashi Y, Ishimitsu T, et al. (1990). Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer 31:261-8
64. Tripathi S, Maurya AK, Kahrana M, et al. (2012). Immunomodulatory property of ethanolic extract of Trigonella foenum-graeceum leaves on mice. Der Pharm Lett 4:708-13
65. Tsang KW, Lam CL, Yan C, et al. (2008). The immunobiology of mushrooms. Exp Biol Med 233:259-76
66. Wasser SP, Weis AL. (1999). Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective. Crit Rev Immunol 19:65-96
67. Wasser SP. (2002). Medicinal mushrooms as a source of anti-tumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60: 258-74
68. Wasterlund E, Andersson R, Aman P. (1993). Isolation and chemical characterization of water-soluble mixed linked b-glucan and arabinoxylans in oat milling fractions. Carbohydr Polym 20:115-23
69. Yoon KN, Alam N, Lee JS, et al. (2011a). Anti-hyperlipidemic effect of dietary Lentinus edodes on plasma, faeces, and hepatic tissues in hypercholesterolemic rats. Mycobiology 39:96-102
70. Yoon KN, Lee JS, Kim HY, et al. (2011b). Appraisal of antihyperlipidemic activities of Lentinus lepideus in hypercholesterolemic rats. Mycobiology 39:283-9
71. Zhang L, Fan C, Liu S, et al. (2011). Chemical composition and antitumor activity of polysaccharide from Inonotus obliquus. J Med Plants Res 5:1251-60
72. Zhang X, Li J, Wong DKW, et al. (2009). Fermented Noni exudate treated dendritic cells directly stimulate B-lymphocyte proliferation and differentiation. Oncol Rep 21:1147-52
73. Zhu M, Chang Q, Wong LK, et al. (1999). Triterperne anti-oxidants from Ganoderma lucidum. Phytother Res 13:529-31